Eastern Mediterranean (WHO region) vs Portugal: Hypertension effective treatment coverage (controlled hypertension)
Eastern Mediterranean (WHO region)
15.5%
in 2019
Portugal
44.6%
in 2019
Eastern Mediterranean (WHO region) rank
7th
Portugal rank
8th
Hypertension effective treatment coverage (controlled hypertension) over time
- Eastern Mediterranean (WHO region)
- Portugal
How they compare
Portugal currently reports 44.6% against 15.5% in Eastern Mediterranean (WHO region), a difference of 29.1%.
That makes Portugal's figure about 2.9 times Eastern Mediterranean (WHO region)'s.
Across all 30 years both countries report, Portugal has been ahead every year.
Eastern Mediterranean (WHO region) ranks 7th and Portugal ranks 8th of 11 groups.
Portugal has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Eastern Mediterranean (WHO region) | Portugal | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 4.9% | 9.5% | 4.6% | Portugal |
| 2000s | 8.4% | 20.0% | 11.6% | Portugal |
| 2010s | 13.9% | 37.9% | 24.0% | Portugal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension effective treatment coverage (controlled hypertension), Eastern Mediterranean (WHO region) or Portugal?
- Portugal, at 44.6% against 15.5% in Eastern Mediterranean (WHO region) as of 2019.
- What is the difference in hypertension effective treatment coverage (controlled hypertension) between Eastern Mediterranean (WHO region) and Portugal?
- 29.1%, with Portugal ahead.
- How many years of comparable data are there for Eastern Mediterranean (WHO region) and Portugal?
- 30 years are reported by both, from 1990 to 2019.
- How do Eastern Mediterranean (WHO region) and Portugal rank globally for hypertension effective treatment coverage (controlled hypertension)?
- Eastern Mediterranean (WHO region) ranks 7th and Portugal ranks 8th of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension effective treatment coverage (controlled hypertension )among adults aged 30-79, age-standardized (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.